Unspecified dopaminergic agent used to augment rehabilitation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified dopaminergic agent used to augment rehabilitation, covering 2025-03-24 to 2025-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke [Phase 1, Phase 2]